Clinical Trial Update: Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor [Phase 2]

View source ↗

Summary

A Phase 2 trial of cisplatin, paclitaxel and gemcitabine with or without Avastin in patients with unknown primary tumors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Unknown Primary Tumor

Drugs mentioned

• Avastin (bevacizumab)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Unknown Primary Tumors | Phase 2 | Status: WITHDRAWN